Two Buyer Perspectives Across the Dermatology and Aesthetics Market

Although dermatology and aesthetics are frequently grouped together in M&A discussions, buyer strategies differ depending on where a platform operates along the clinical-to-consumer spectrum. These differences are reflected in acquisition strategy, growth priorities, and operational focus.

Medical DermatologyPlatform

To help practice owners understand how strategic buyers and private equity investors evaluate these segments, this article reviews perspectives from two experienced acquirers operating at different ends of the dermatology and aesthetics spectrum. One represents a multi-state medical dermatology platform, and the other represents an aesthetics-focused platform.

A medical dermatology–focused platform is typically built around comprehensive clinical care, with supporting cosmetic services and ancillary treatments. Growth strategies often emphasize regional density within defined geographies rather than broad national expansion.

From an acquisition standpoint, these platforms generally prioritize practices with the following characteristics:

• General medical dermatology as the clinical foundation
• Strong clinical reputation and patient access
• A diversified provider base, including dermatologists and advanced practitioners
• Opportunities to build regional density within targeted markets

Growth models typically extend beyond acquisitions to include de novo clinic development, provider recruitment,

Although both platforms are active acquirers in the broader dermatology and aesthetics market, they do not directly compete. One is centered on comprehensive medical dermatology with supporting cosmetic services, whereas the other is structured around elective aesthetic treatments and a consumer-driven experience.

Together, these perspectives provide insight into how buyers evaluate opportunities across these two segments and the implications for physician practice owners. This article summarizes and analyzes those perspectives.

Aesthetics Platform

Aesthetics-focused platforms operate at the consumer end of the spectrum, emphasizing elective, cash-pay services and curated patient experience. These platforms often apply operating models similar to those used in multi-unit con­ sumer service businesses.

Acquisition strategies in this segment typically emphasize:

• Injectables, laser therapies, and energy-based treatments

• Consistent patient experience and standardized brand delivery

• Provider professionalism, accountability, and cultural alignment

• Entry into markets through flagship practices that sup­port regional expansion Compared with medical dermatology, aesthetics plat­ forms are less constrained by payer dynamics and clinical workforce shortages. As a result, greater emphasis is placed on brand execution, innovation, and consumer engagement. Acquisitions often serve as a foundation for building scalable infrastructure in a fragmented market.

MARKET OUTLOOK

Despite differences in positioning, both segments demon­strate sustained growth potential. However, the underlying drivers of opportunity differ.

Aesthetics: Fragmentation, Brand Development, and Innovation

The aesthetics market remains highly fragmented, with limited national or regional brand consolidation. Many practices operate independently with varying levels of opera­tional standardization.

This fragmentation creates opportunities for platforms capable of establishing regional density and delivering con­sistent patient experience. Innovation also plays a central role, with new devices, biologics, and treatment modalities entering the market rapidly.

Platforms that can evaluate innovations, train providers, and implement new treatments safely at scale may maintain competitive positioning as consumer preferences evolve. For practice owners, this underscores the importance of adapt­ability in a consumer-driven environment. and same-site growth. This approach reflects the operational realities of medical dermatology, in which access to care, provider availability, and infrastructure are critical to longterm sustainability.

Derm: Access to Care and Operational Scale

In medical dermatology, growth opportunities are strongly influenced by access to care and the ability to achieve operational scale. Many markets continue to include single-site and small group practices that may require succession planning.

Increasing administrative complexity, including payer negotiations, regulatory compliance, staffing, and credentialing, has made scale progressively more important.

A nationwide shortage of dermatologists further contributes to these dynamics, particularly in certain geographic regions. Scaled platforms may address these challenges through acquisitions, de novo development, provider recruitment, and the integration of advanced practitioners to expand access while maintaining quality of care.

POST-TRANSACTION EXPECTATIONS AND INTEGRATION

Post-transaction integration is a critical factor in long-term outcomes. Buyers increasingly evaluate not only the quality of a practice but also the likelihood of successful integration and sustained collaboration.

Aesthetics Platforms

In aesthetics, integration efforts typically focus on achieving consistency across clinical operations, marketing, purchasing, and branding while maintaining provider engagement.

Because patient experience and provider relationships are central to value, communication during integration is essential. Practices that demonstrate organizational structure, accountability, and openness to standardization tend to transition more effectively.

Medical Dermatology Platforms

In medical dermatology, post-transaction priorities emphasize continuity of care and provider engagement. Buyers typically seek long-term partnerships with providers who are committed to ongoing growth within a larger organization.

Practices in which leadership remains engaged and participates in recruitment and operational improvement are more likely to realize the benefits of scale. In contrast, disengagement following a transaction may limit performance improvements.

CONCLUSION

Understanding where a practice falls along the medical dermatology–aesthetics spectrum is important for aligning with appropriate buyers and preparing for a transaction. Positioning, operational readiness, and provider engagement all influence buyer interest and long-term value. 

CLINT BUNDY

• Managing Director, The Bundy Group

Charlotte, N.C.

DREW THOMAS

• Director, The Bundy Group

Charlotte, N.C.